Last reviewed · How we verify
Cortisol — Competitive Intelligence Brief
marketed
Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Cortisol (Cortisol) — University of Zurich.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cortisol TARGET | Cortisol | University of Zurich | marketed | Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible | ||
| Cortef | hydrocortisone | Generic (originally Merck/Upjohn) | marketed | Corticosteroid [EPC] | Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible | 1952-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
- — Cortef · 9717740 · Method of Use · US
- — Cortef · 9675559 · Method of Use · US
- — Cortef · 9649280 · Formulation · US
- — Cortef · 12133914 · Method of Use · US
- — Cortef · 11904046 · Formulation · US
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
Cite this brief
Drug Landscape (2026). Cortisol — Competitive Intelligence Brief. https://druglandscape.com/ci/cortisol. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab